Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 3, 2019
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation BurdenGo Makimoto, Kadoaki Ohashi, Shuta Tomida, et al.Oncology Letters|November 16, 2020
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reactionKazuya Nishii, Kadoaki Ohashi, Tomoki Tamura, et al.Journal of Clinical Medicine|November 27, 2024
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational StudyHisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.Respiratory Investigation|May 30, 2024
Predictors of exacerbation in Japanese patients with severe asthma: Analysis of the severe asthma research program (Okayama-SARP) cohortHisao Higo, Akihiko Taniguchi, Satoru Senoo, et al.Internal Medicine (Tokyo, Japan)|May 21, 2025
A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion: A Case ReportTakahiro Baba, Hirofumi Inoue, Hiromi Matsuoka, et al.Cancer Science|January 7, 2021
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancersHiromi Watanabe, Eiki Ichihara, Hiroe Kayatani, et al.JCI Insight|June 17, 2025
Fine mapping of heterozygous IL6ST nonsense variants underlying autosomal dominant hyper-IgE syndromeKosuke Ashihara, Takaki Asano, Kanako Takeuchi, et al.Cancer Immunology Research|July 8, 2022
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung CancerKazuya Nishii, Kadoaki Ohashi, Shuta Tomida, et al.Cancer Science|June 2, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse ModelTakaaki Tanaka, Masato Fujitani, Masataka Taoka, et al.Respirology (Carlton, Vic.)|June 4, 2026
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective ValidationTetsu Hirakawa, Kakuhiro Yamaguchi, Shun Takao, et al.Pageof 5